Biological therapy for prostate cancer
Biological therapy may be used to reduce the risk of bone-related events in prostate cancer. It is also called biotherapy or biological response modifiers (BRMs).
Biological therapy uses natural or manufactured substances to kill, control or change the behaviour of cancer cells. Different types of biological therapies work in different ways.
Biological therapy may be used:
- to strengthen bone and prevent osteoporosis due to hormonal therapy
- reduce the risk of bone complications due to metastatic prostate cancer
Drugs, doses and schedules vary from person to person.
Biological therapy drugs
RANK-ligand inhibitor is a biological therapy in which a monoclonal antibody blocks the action of RANK ligand - a protein that promotes bone resorption. This helps to strengthen bone.
The most common biological therapy drug used to treat prostate cancer is:
For more detailed information on specific drugs, go to sources of drug information.
Access to services in your community
The Canadian Cancer Society’s Community Services Locator helps cancer patients and their families find the services and programs they need in their community.